|
Sep 5
|
Acasti to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
|
|
Jun 27
|
Acasti Announces Achievement of 50% Enrollment in Pivotal Phase 3 STRIVE-ON Safety Trial
|
|
Jun 21
|
Acasti Announces Year-End 2024 Financial Results, Provides Business Update
|
|
Nov 13
|
Acasti Announces Second Quarter 2024 Financial Results and Business Highlights
|
|
Aug 9
|
Acasti to Present GTX-104 Pharmacokinetic Comparison Data at Neurocritical Care Annual Meeting
|